| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/24/2005 | WO2005111072A2 Notch-based fusion proteins and uses thereof |
| 11/24/2005 | WO2005110502A1 Absorption of pain-causing agents |
| 11/24/2005 | WO2005110483A2 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 11/24/2005 | WO2005110482A1 Percutaneous pharmaceutical preparation for external use containing nonsteroidal antiinflammatory analgesic |
| 11/24/2005 | WO2005110473A2 Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases |
| 11/24/2005 | WO2005110466A1 Hydrogel interferon formulations |
| 11/24/2005 | WO2005110444A1 Therapeutic or preventive agent for eye disease |
| 11/24/2005 | WO2005110442A2 Peritoneal dialysis solution |
| 11/24/2005 | WO2005110439A2 Stabilized hyaluronan preparations and related methods |
| 11/24/2005 | WO2005110436A2 Macromolecule-containing sustained release intraocular implants and related methods |
| 11/24/2005 | WO2005110434A1 Topical treatment and prevention of human papilloma virus (hpv) infection |
| 11/24/2005 | WO2005110430A1 Method of use of carboxylated polysaccharides topically on the eyeball |
| 11/24/2005 | WO2005110427A1 Stable oral pharmaceutical preparation comprising fosfomycin, which is intended for diabetic patients |
| 11/24/2005 | WO2005110425A1 Polymer-based sustained release device |
| 11/24/2005 | WO2005110424A1 Biodegradable intraocular implants containing prostamides |
| 11/24/2005 | WO2005110420A1 Controlled-release formulations containing vardenafil |
| 11/24/2005 | WO2005110419A1 Controlled-release formulations containing vardenafil |
| 11/24/2005 | WO2005110418A2 Transdermal administration of phycotoxins |
| 11/24/2005 | WO2005110407A2 Nanoparticle dispersion containing lactam compound |
| 11/24/2005 | WO2005110401A1 Pharmaceutical nitrones |
| 11/24/2005 | WO2005110395A1 System and device for magnetic drug targeting with magnetic drug carrier particles |
| 11/24/2005 | WO2005110385A1 Composition for prolonging the residence time of drugs in the gut and use thereof |
| 11/24/2005 | WO2005110382A1 Dermal system of two patches detachably secured to each other for providing therapy to an area of the body |
| 11/24/2005 | WO2005110381A1 Topical methadone compositions and methods for using the same |
| 11/24/2005 | WO2005110380A1 Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies |
| 11/24/2005 | WO2005110379A2 Pulmonary malarial vaccine |
| 11/24/2005 | WO2005110378A1 Rapidly disintegrating tablets comprising calcium carbonate |
| 11/24/2005 | WO2005110377A1 Gel composition comprising charged polymers |
| 11/24/2005 | WO2005110376A2 Rapidly disintegrating tablets comprising titanium dioxide |
| 11/24/2005 | WO2005110375A1 Nutritional supplement for treatment of ocular diseases |
| 11/24/2005 | WO2005110374A1 Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| 11/24/2005 | WO2005110373A1 Rapidly soluble granulate of bromohexine or bromohexine hydrochloride, method for the production of said granulate and the use thereof |
| 11/24/2005 | WO2005110372A1 Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water |
| 11/24/2005 | WO2005110371A1 Macrogol preparation |
| 11/24/2005 | WO2005110370A1 Oil-in-water emulsion for delivery |
| 11/24/2005 | WO2005110369A2 Sustained-release microspheres and methods of making and using same |
| 11/24/2005 | WO2005110368A1 Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision |
| 11/24/2005 | WO2005110367A2 Sustained release intraocular implants and methods for preventing retinal dysfunction |
| 11/24/2005 | WO2005110366A1 An estradiol derivative or an estratopone derivative containing sustained release intraocular implant as well as related methods of manufacturing |
| 11/24/2005 | WO2005110365A1 Intravitreal implants in conjunction with photodynamic therapy to improve vision |
| 11/24/2005 | WO2005110364A2 Drug delivery systems and methods for treatment of an eye |
| 11/24/2005 | WO2005110363A2 Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles |
| 11/24/2005 | WO2005110362A1 Biodegradable ocular implants with long-term release characteristics |
| 11/24/2005 | WO2005110361A2 Nucleotide-cochleate compositions and methods of use |
| 11/24/2005 | WO2005110360A2 Compositions for injection |
| 11/24/2005 | WO2005110359A1 Inhalation powder formulations containing enantiomerically pure beta-agonists |
| 11/24/2005 | WO2005110358A2 Film-shaped estriol-containing medicament for oral administration |
| 11/24/2005 | WO2005110346A1 Oral care products comprising calcium phosphates |
| 11/24/2005 | WO2005110345A1 Oral care products comprising silica |
| 11/24/2005 | WO2005110277A2 Carboxylated polysaccharides and method of preparation and use |
| 11/24/2005 | WO2005110120A1 Pellets comprising protein and nutritional supplements and method for preparation thereof |
| 11/24/2005 | WO2005110114A1 Liquid nutritional supplement and method for preparing same |
| 11/24/2005 | WO2005110082A2 Antimicrobial articles |
| 11/24/2005 | WO2005110022A2 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 11/24/2005 | WO2005110002A2 Anti-inflammatory and anticeptic suppository exhibiting a regeneration effect |
| 11/24/2005 | WO2005087253A3 Interferon-beta for anti-virus therapy for respiratory diseases |
| 11/24/2005 | WO2005086639A3 Improved efficacy and safety of targeted particulate agents with decoy systems |
| 11/24/2005 | WO2005084685A3 Boronate medicaments suitable for short duration anticoagulation |
| 11/24/2005 | WO2005082332A3 Dissolvable film comprising an active ingredient and method of manufacture |
| 11/24/2005 | WO2005079317A3 Prostate hypertrophy treatment composition and method |
| 11/24/2005 | WO2005076829A3 Stable loratadine spill resistant formulation |
| 11/24/2005 | WO2005072706A3 Nanosuspensions of anti-retroviral agents for increased central nervous system delivery |
| 11/24/2005 | WO2005065665A3 Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
| 11/24/2005 | WO2005063200A3 Probiotic tablet formulations |
| 11/24/2005 | WO2005062898A3 Enhanced absorption of modified release dosage forms |
| 11/24/2005 | WO2005062818B1 Treatment of ophthalmic conditions |
| 11/24/2005 | WO2005046641A3 Compositions and methods for treating a posterior segment of an eye |
| 11/24/2005 | WO2005032489A3 Coated metal pyrithione particles for treatment of microorganisms |
| 11/24/2005 | WO2005025535A8 Methods for preparing pharmaceutical compositions |
| 11/24/2005 | WO2005018708A3 Magnetic circumferentially coupled implantable pump |
| 11/24/2005 | WO2005011647A2 Pharmaceutical composition |
| 11/24/2005 | WO2005009357A3 Controlled release compositions |
| 11/24/2005 | WO2004104021A3 Controlled release of active agents utilizing repeat sequence protein polymers |
| 11/24/2005 | WO2004091630A8 Remedies for diseases to be applied to eye |
| 11/24/2005 | WO2004089313A3 Novel olanzapine forms and related methods of treatment |
| 11/24/2005 | WO2004060303A3 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 11/24/2005 | WO2003077846A3 New therapeutic method of delivering a medicament to avoid irritating effects on membranes of user |
| 11/24/2005 | US20050261668 Drug delivery device |
| 11/24/2005 | US20050261632 High-Aspect-Ratio Microdevices and Methods for Transdermal Delivery and Sampling of Active Substances |
| 11/24/2005 | US20050261631 Microneedle devices and microneedle delivery apparatus |
| 11/24/2005 | US20050261361 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 11/24/2005 | US20050261360 Dissolving the crystalline form in acetone, allowing to convert to amorphous form and then precipitating it out |
| 11/24/2005 | US20050261359 Novel processes for preparing amorphous atorvastatin hemi-calcium |
| 11/24/2005 | US20050261335 Carvedilol formulations |
| 11/24/2005 | US20050261280 Stabilized antihistamine syrup |
| 11/24/2005 | US20050261271 Dipeptidyl peptidase inhibitors |
| 11/24/2005 | US20050261239 Use of ATP for the manufacture of a medicament for treating certain inflammatory conditions, oxidative stress and fatigue |
| 11/24/2005 | US20050261208 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease |
| 11/24/2005 | US20050261173 Antifungal parenteral products |
| 11/24/2005 | US20050261163 Pharmaceutical products, preparation and uses thereof |
| 11/24/2005 | US20050261134 Aqueous compositions comprising vesicles having certain vesicle permeability |
| 11/24/2005 | US20050260597 Transfection reagents |
| 11/24/2005 | US20050260544 Novel device |
| 11/24/2005 | US20050260322 Gel-type drink composition |
| 11/24/2005 | US20050260280 Contact lens and eye drop rewetter compositions and methods |
| 11/24/2005 | US20050260277 Method and formula for anti-tumor and anti-matastatic effect |
| 11/24/2005 | US20050260276 Methods and articles for the delivery of therapeutic agents |
| 11/24/2005 | US20050260275 Encapsulated peptide copper complexes and compositions and methods related thereto |
| 11/24/2005 | US20050260274 Preparation of nanoparticles |
| 11/24/2005 | US20050260273 Applicatin of a bioactive agent in a solvent composition to produce a target particle morphology |